Navigation Links
Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
Date:8/19/2007

Administration (FDA) to include these data in the prescribing information in the U.S.

Pharmion is also developing a next generation product, oral Azacitidine, for the treatment of MDS and other cancers where demethylation can provide an anti-tumor effect. Oral Azacitidine is the subject of a Phase 1 multi-center, open label dose escalation trial that will assess the maximum tolerated dose, dose limiting toxicities and safety of a seven day, multi-cycle oral dosing regimen of oral Azacitidine in patients with MDS and AML. In addition, the trial will examine pharmacokinetics and pharmacodynamic effects of orally administered Azacitidine, as compared with parenteral Vidaza.

Pharmion will hold a conference call to discuss these results later this morning, August 2, at 9:00 a.m. ET. The conference call will be simultaneously webcast on the Company's web site at http://www.pharmion.com, and archived for future review. Dial-in numbers for the conference call for institutional investors and analysts are as follows: participants from the U.S. 866.314.5232, International participants 617.213.8052, passcode: 71992680.

About the Trial Design

This was the largest randomized study ever conducted in higher-risk MDS. The study was a multi-center, randomized, open-label, parallel-group, Phase 3 trial of subcutaneous (SC) Vidaza (administered at 75/mg/m2/day SC for seven consecutive days every 28 days) plus best supportive care versus CCR plus best supportive care for the treatment of MDS. CCR consisted of one of three physician selected regimens: best supportive care alone, low-dose cytarabine plus best supportive care or standard chemotherapy plus best supportive care. EPO and prophylactic G-CSF use was not permitted. The CCR represented standard of care within the territories where the trial was conducted. The study evaluated 358 higher-risk MDS patients at sites in the U.S., Europe and Australia. Patients
'/>"/>

SOURCE Pharmion Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
2. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... PharmaPoint: Type 1 Diabetes - Global Drug Forecast ... diabetes (T1D) is an autoimmune disease that permanently destroys beta ... can no longer produce insulin. Over the last 90 years, ... other treatment can be offered to a patient who is ... different times of action - long-acting as well as short ...
(Date:5/27/2015)... NEW YORK , May 27, 2015  Precision ... announced the findings from its 2015 Digital Trends Study ... decision makers are aware of the concepts of big ... fully implement them.  The Health Information ... incentives for healthcare providers to make use of electronic ...
(Date:5/27/2015)... , May 27, 2015  LumiThera Inc., ... non-invasive photobiomodulation (PBM) treatment for ocular disorders and ... Washington State Life Sciences ... 3 recipients of the LSDF matching grants worth ... treatment for subjects with dry age-related macular degeneration ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3LumiThera Receives LSDF Commercialization Grant Award 2
... , LAVAL, QC, Aug. 5 /PRNewswire-FirstCall/ - Labopharm Inc. ... it has filed a New Drug Submission (NDS) with ... novel formulation of the antidepressant trazodone. , "We are ... Canada," said James R. Howard-Tripp, President and Chief Executive ...
... WORTH, Texas, Aug. 4 Of the 600,000-800,000 people trafficked across international ... by 2010, human trafficking will be the No. 1 crime worldwide. ... chairman of the department of forensic and investigative Genetics and co-director of ... University of North Texas (UNT) Health Science Center , ...
Cached Medicine Technology:Labopharm files New Drug Submission with Health Canada for novel antidepressant 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 3DNA Helps Reunite Children With Their Families 2DNA Helps Reunite Children With Their Families 3
(Date:5/27/2015)... The BBB Code of Business Practices ... enhance customer trust and confidence in business. The Code ... principles that summarize important elements of creating and maintaining ... business accreditation by BBB. Businesses based in the United ... application procedures will be accredited by BBB. , To ...
(Date:5/27/2015)... Continuing its commitment to finding a cure ... community, SmartPractice® donated $25,000 to HonorHealth Breast ... Vice President of Human Resources Meg Mosher and SmartScrubs ... to Paulla Miller, Sherry Gage, Dr. Linda Greer and ... on April 30. The center is located at 19646 ...
(Date:5/27/2015)... Allred Dental located in San Marcos, CA ... need extensive dental treatment - understand the oral issues they ... their problems. , Dr. Jeff Allred calls it “Dental Case ... assessment of the patient’s oral health and problems together with ... oral health problems. , “The dental case planning process starts ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Black ... customer satisfaction surveys in the multiple services and ... to determine the highest ranked Electronic Health and ... of a special research focus on implemented EHR ... those software vendors with the highest scores in ...
(Date:5/27/2015)... May 27, 2015 The MedSpa at ... FDA-approved dermal filler treatments in Abilene, Texas: Xeomin®, Belotero ... the appearance of glabellar lines, better known as the ... Balance® is designed to treat smoker’s lines around the ... chin, while Radiesse® improves the appearance of smile lines ...
Breaking Medicine News(10 mins):Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2
... , FRIDAY, Aug. 5 (HealthDay News) -- Smoking ... atrial fibrillation, a new study warns. U.S. researchers reviewed ... who were followed for an average of 13 years, and ... time. The risk of the abnormal heart rhythm was ...
... (HealthDay News) -- Children with HIV who receive antiretroviral ... (lipid) levels, and would benefit from guidelines aimed at ... findings are published in JAIDS: Journal of Acquired ... first crucial step in minimizing cardiovascular disease complications and ...
... in Spanish . , ANN ARBOR, Mich. ... be used safely and effectively even in tumors from the ... the University of Michigan Comprehensive Cancer Center. Sentinel lymph ... first node where cancer would likely spread. If that node ...
... --,Smokers who take a multivitamin pill may think they can ... affects of cigarettes, according to a new study. Researchers ... will reduce their risk of cancer, allowing them to light ... a virtuous behavior for a subsequent indulgence, known as the ...
... WHAT: Scientists from around the world will gather ... order to improve health through advances in pharmaceutical sciences ... In recognition of AAPS,s 25th anniversary, this year,s meeting, ... sessions, including more than 60 symposia and roundtables. ...
... , THURSDAY, Aug. 4 (HealthDay News) -- American military veterans ... suicide than fellow students who have never been in the ... poll paints a grave picture of these students, mental health: ... they have considered suicide at some point in their lives, ...
Cached Medicine News:Health News:Children's HIV Drugs May Cause High Cholesterol 2Health News:Sentinel node biopsy safe, effective in head and neck melanomas, U-M study finds 2Health News:Smokers Mistakenly Believe Vitamins Protect Them From Cancer 2Health News:Many Military Vets in College Plagued By Thoughts of Suicide 2Health News:Many Military Vets in College Plagued By Thoughts of Suicide 3
... 6-Place Rotor has a standard 1.5ml rotor and ... adapters. Easy operation (no switches to mess with). ... press the plastic tab to open. Starts and ... and 2000 x g. Only five inches in ...
... which allows user to stop rotor before opening ... stainless steel pin is virtually indestructible. Lid release ... microcentrifuge tubes at low to medium speed (up ... inch x 6 inch footprint. Starts and stops ...
Inquire...
Inquire...
Medicine Products: